Bound Therapeutics is featured in Genetic Engineering & Biotechnology News
Why Blocking microRNAs in Triple Negative Breast Cancer Is so Difficult While a triple negative score is hardly ever a good thing, for breast cancer it is especially troubling. Triple-negative breast cancer (TNBC) refers to a disease scenario where the cancer cells do not express the genes for estrogen, progesterone, or HER2/neu receptors simultaneously—making this […]
Regulatory & Non-coding RNAs at Cold Spring Harbor Laboratory
